NARI Inari Medical
- 41.990
- +0.390+0.94%
Inari Medical News
Analysts Are Bullish on Top Healthcare Stocks: Qiagen (QGEN), Inari Medical (NARI)
Canadian Investment Banking Group: Maintaining the Inari Medical (NARI.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $75.00 to $55.00.
Inari Medical Analyst Ratings
Bank of America Securities Sticks to Their Buy Rating for Inari Medical (NARI)
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)
Inari Medical Analyst Ratings
Needham Maintains Buy on Inari Medical, Lowers Price Target to $57
Inari Medical Analyst Ratings
Canadian Investment Banking Group: Maintaining the Inari Medical (NARI.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $75.00 to $75.00.
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inari Medical (NARI) and Roivant Sciences (ROIV)
Inari Medical Analyst Ratings
Truist Securities Maintains Hold on Inari Medical, Lowers Price Target to $52
Needham Reiterates Buy on Inari Medical, Maintains $72 Price Target
Inari Medical Analyst Ratings
Inari Medical Buy Rating Justified by Industry-Standard Physician Payments and Resilient Sector Trends
Piper Sandler Cuts Inari to Neutral; Cites Slowing Growth, DOJ Probe
Critical Insights From Inari Medical Analyst Ratings: What You Need To Know
Needham Reiterates Buy on Inari Medical, Maintains $72 Price Target
Inari Medical (NARI) Gets a Hold From Truist Financial
Morgan Stanley Lowers Price Target on Inari Medical to $75 From $83, Keeps Overweight Rating
Analysis
Price Target
No Data
